The investigation centers on potential losses sustained by shareholders following the market’s reaction to the earnings miss. Levi & Korsinsky is currently reviewing the company’s recent disclosures and trading activity to determine if investors were misled. Participation is open to any shareholder who incurred financial losses, regardless of whether they currently hold the stock or have already sold their positions.
Levi & Korsinsky Launches Investigation Following Dr. Reddy's Stock Slump
A 9% plummet in Dr. Reddy's Laboratories shares has triggered a securities investigation by law firm Levi & Korsinsky. The inquiry follows the company’s Q1 FY27 financial report, which revealed a 5.6% drop in revenue and a staggering 68.7% decline in profit compared to the previous year.
There are no upfront costs for those seeking a review of their losses, as the firm typically operates on a contingency basis. Investors are encouraged to compile brokerage records, including purchase dates and share quantities, to assist in evaluating their claims. Joseph E. Levi is heading the outreach from the firm’s New York office, inviting affected parties to submit documentation regarding their trading history.
Comments (0)
No comments yet. Be the first!